Self-crosslinkable chitosan-hyaluronic acid dialdehyde nanoparticles for CD44-targeted siRNA delivery to treat bladder cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Self-crosslinkable chitosan-hyaluronic acid dialdehyde nanoparticles for CD44-targeted siRNA delivery to treat bladder cancer

Published:2021-02 Issue:2 Volume:6 Page:433-446
ISSN:2452-199X
Container-title:Bioactive Materials
language:en
Short-container-title:Bioactive Materials

Author:

Liang Ye^ORCID,Wang Yonghua,Wang Liping,Liang Zhijuan,Li Dan,Xu Xiaoyu,Chen Yuanbin,Yang Xuecheng,Zhang Hongbo^ORCID,Niu Haitao

Funder

National Natural Science Foundation of China

Taishan Scholar Program of Shandong Province

Key Research and Development Program of Shandong Province

China Postdoctoral Science Foundation

Qingdao Postdoctoral Application Research Project

Academy of Finland

Sigrid Juselius Foundation

Qingdao University

Publisher

Elsevier BV

Subject

Biomedical Engineering,Biomaterials,Biotechnology

Reference65 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;Ca - Cancer J. Clin.,2018

2. Cluster of differentiation 44 (CD44) gene variants: a putative cancer stem cell marker in risk prediction of bladder cancer in north Indian population;Verma;Indian J. Clin. Biochem.,2017

3. Bladder cancer diagnosis and follow-up: the current status and possible role of extracellular vesicles;Oeyen;Int. J. Mol. Sci.,2019

4. A novel monoclonal antibody KMP1 has potential antitumor activity of bladder cancer by blocking CD44 in vivo and in vitro;Chen;Cancer Med,2018

5. Stratification of Intermediate-Risk Non-muscle-invasive Bladder Cancer Patients: Implications for Adjuvant Therapies;Soria,2020

Cited by 132 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effective Strategies in Designing Chitosan-hyaluronic Acid Nanocarriers: From Synthesis to Drug Delivery Towards Chemotherapy;Current Drug Delivery;2025-01

2. Current advances in non-viral nanoparticle-based gene therapy for effective management of cancer;Journal of Drug Delivery Science and Technology;2024-10

3. Targeted Inhibition of Lymphovascular Invasion Formation with CREKA Peptide-Modified Silicasomes to Boost Chemotherapy in Bladder Cancer;Nano Letters;2024-08-13

4. Advanced gene therapy system for the treatment of solid tumour: A review;Materials Today Bio;2024-08

5. Chitosan Nanoparticles for Targeted Cancer Therapy: A Review of Stimuli-Responsive, Passive, and Active Targeting Strategies;International Journal of Nanomedicine;2024-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3